Last reviewed · How we verify
NCT06381336: TRAK-SILVER
A Digital Home-Based Physiotherapy Program for Active Aging
NA trial testing TRAK-SILVER platform in Frail Elderly Syndrome in 72 participants. Completed in 7 November 2022.
7 November 2022
Quick facts
| Lead sponsor | Trak Health Solutions S.L. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 23 March 2022 |
| Primary completion | 7 November 2022 |
| Estimated completion | 7 November 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- TRAK-SILVER platform
Conditions studied
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
- Older Adults — all drugs for Older Adults →
Sponsor
Trak Health Solutions S.L. — full company profile →
Who can join
65 and older, any sex, with Frail Elderly Syndrome or Older Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial will aim to understand the effects of the TRAK-SILVER digital platform on pre-frail and older adults living at home, assessing its impact on physical activity level, emotional variables, and overall quality of life. Participant satisfaction with the digital treatment will also be evaluated. This research will provide insight into the utility and acceptance of the digital platform as a personalised and accessible digital physiotherapy program for this population, advancing understanding in the field. The participants will undergo a 3-month physiotherapy program using the TRAK-SILVER platform or a paper guide based on their assigned group. Additionally, weekly uploads of health-promoting audiovisual content will enhance the intervention's holistic approach to improving older adults' well-being and functional capacity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06381336
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frail Elderly Syndrome
Currently open trials in the same condition.
- NCT06857981 — Patient's Database: Prepare for Your Surgery Program · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06444321 — INTEgRated Health CARE for Patients With Frailty and Heart Failure · NA · recruiting
- NCT05993754 — Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams · NA · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
Other Trak Health Solutions S.L. trials
Trials by the same sponsor.
- NCT06720779 — Virtual Rehabilitation Platform for Patients With Knee Prothesis · NA · recruiting
- NCT06796309 — Assessment of Rural Health Care: Implementing TRAK Digital Tool for Quality and Accessible Services · NA · recruiting
- NCT06699875 — Conventional Therapy vs. Telerehabilitation With TRAK in Patients Undergoing Axillary Lymph Node Removal · NA · completed
- NCT06492551 — Post-COVID-19 Patients With Trak Tool · NA · completed
- NCT06498453 — Effectiveness of Telerehabilitation With Trak in Knee and Shoulder Pathology: A Randomized Clinical Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06381336 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Trak Health Solutions S.L.
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06381336.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing